The PET100 gene helps your cells assemble complex IV, an essential part of the mitochondria, the structures that make energy. This gene plays an important role in keeping energy production steady, especially in tissues with high energy needs such as the brain and muscles. If it does not work properly, cells may not make enough energy. Pathogenic variants in the PET100 gene can cause a mitochondrial condition that often starts in infancy, with poor muscle tone, feeding problems, developmental delay, seizures, or breathing difficulties.
What is a gene?
Genes are sections of DNA that hold instructions your cells use to make molecules or regulate processes in the body. Some genes give the directions for producing proteins, the parts of cells that do the work. Others mainly control when certain processes take place, where they happen, and how strongly they run. Together, genes affect how the body develops and works, and they can influence how you respond to food, stress, or medicines. For a closer look at this topic, you can read more in the LearnHub.
Overview
PET100Gene function
What if the gene works
The PET100 gene helps mitochondria, your cells' energy centers, complete an important step in making energy from oxygen. This supports steady energy supply, especially in the brain, heart, and muscles.
Risk
What if the gene does not work
Pathogenic variants in the PET100 gene can cause a mitochondrial condition that often begins in infancy, with poor feeding, low muscle tone, developmental delay, lactic acidosis, and sometimes heart problems. Milder and more severe variants can change timing and severity.
Treatment
What does that mean for your treatment
No PET100-specific treatment or drug selection approach is currently established, and care is guided by the person’s symptoms and general mitochondrial disease management.
Gene function
What if the gene works
Deep inside your cells, mitochondria need the PET100 gene to keep one key energy step running smoothly. This gene helps build complex IV, a protein group that uses oxygen during energy production. In simple terms, PET100 gene function centers on helping mitochondria use oxygen to make energy.
The PET100 gene helps your cells put together complex IV inside mitochondria. This protein group needs the right parts in the right place to work smoothly.
PET100 also helps keep complex IV steady within the inner mitochondrial membrane. That stable setup supports reliable day to day energy production.
By helping complex IV form properly, PET100 supports the step where cells use oxygen to finish making ATP, the cell’s main energy source. This helps many tissues meet everyday energy needs.
What is a variant?
A genetic variant is a small change in the DNA sequence within a gene. These changes are common and are part of normal human diversity, including differences in appearance, metabolism, or how the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. At times, though, a variant can change how a gene functions more significantly and may contribute to or directly cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the PET100 gene usually disrupt assembly of cytochrome c oxidase (complex IV, part of the cell’s energy-making system), so this protein complex is unstable or may not form at all. This is how PET100 gene variants affect mitochondria: cells have lower complex IV activity and make energy less efficiently. Some variants may leave a small amount of function, while more severe variants can nearly eliminate it and are often linked to earlier, more marked mitochondrial disease.
How variants are linked to conditions
Pathogenic variants in both copies of the PET100 gene cause mitochondrial complex IV deficiency, nuclear type 17, a rare inherited mitochondrial condition. In reported families, PET100-related mitochondrial disease has often been linked with Leigh syndrome or a Leigh-like condition. People may develop symptoms in infancy or early childhood, often with developmental slowing or loss of skills, low muscle tone, weakness, feeding problems, and episodes of lactic acidosis.
A variant is not necessarily a diagnosis
Genetic variants are a usual part of human biology and are common throughout the general population. Most do not have a direct effect on health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when multiple genes and environmental factors play a role. In some situations, though, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For PET100, risk is mainly set by inheritance: a child is affected when they inherit a disease-causing change in both copies of the PET100 gene, one from each parent. There is not yet broadly confirmed evidence that lifestyle or environmental factors meaningfully change this risk.
Inheritance of PET100 variants
Variants in the PET100 gene are inherited in an autosomal recessive pattern. This means a child usually develops a PET100-related condition only if they inherit one nonworking copy from each parent. Parents who each carry one PET100 gene variant are typically unaffected, but with each pregnancy there is a 25% chance of having an affected child, a 50% chance of having a child who is a carrier, and a 25% chance of having a child with no familial variant. In families asking how PET100 variants are inherited, the key point is that sons and daughters are affected equally.
What does my PET100 result mean for my family?
Changes in the PET100 gene are linked to a rare inherited condition that usually runs in families in a recessive way, so parents are often healthy carriers. Brothers and sisters may also be carriers or, more rarely, may also be affected. Other relatives on both sides of the family may carry the same gene change, especially if there is a family history of similar symptoms.
Genetic information
Genetic testing
How you find out about variants
To find variants in the PET100 gene, doctors use genetic testing on a blood sample, saliva, or cheek swab. PET100 genetic testing usually reads the gene's DNA code and compares it with a reference sequence to look for changes linked to mitochondrial disease. Results can show whether a variant is present, but they are interpreted alongside symptoms and family history.
When should I consider getting a genetic test?
Consider PET100 testing if a child has signs of a rare mitochondrial condition, such as severe muscle weakness, feeding problems, delayed development, seizures, or high lactic acid levels, especially early in life. It can also be helpful when a close relative has a confirmed PET100 change or unexplained mitochondrial disease.
A genetic result is only one part of your health story
Genetic results can provide useful insight, but how much they reveal varies based on the condition and the type of variant involved. Many factors, including age, lifestyle, environment, and medical history, influence how the body works over time. For some conditions, especially those shaped by many genes, genetic information provides context rather than certainty and is most useful when considered alongside other parts of care. In other situations, a genetic result may give a clear answer. In areas such as medication response, genetic results can also help make sense of individual experiences.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in DNA can change how the body breaks down a drug, moves it through the body, or responds to its effects at the target tissue. This is common and helps explain why the same treatment works well for one person, has less effect in another, or causes more side effects in someone else.
What is Pharmacogenetics?
Pharmacogenetics is the area of study that examines how differences in genes affect the way people respond to medications. It focuses on patterns between genes and drugs to help explain why the same treatment can work differently from one person to another. For many medicines, genes influence both how strong a drug’s effects are and how the body handles it. This information can support treatment decisions that are both better informed and more individualized. More detail on this topic is available in the LearnHub.
Drugs influenced by the PET100 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choice or dose. For questions about medicines, side effects, or changes in your health, talk with your doctor or pharmacist.
History
PET100 entered the medical literature through work on rare families with an inherited mitochondrial condition, rather than through a widely known public story. Its name traces back to earlier yeast research, where “PET” genes were used to study problems with cellular energy use. Building on this early work, scientists later linked the human PET100 gene to a similar biological pathway and identified disease causing variants in affected children. Reports in the 2010s helped establish PET100 as part of the growing group of genes involved in mitochondrial disease. Since then, its place in genetic testing panels for suspected mitochondrial conditions has become clearer.